Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy

被引:137
作者
Epstein, JI
Sanderson, H
Carter, HB
Scharfstein, DO
机构
[1] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Johns Hopkins Hosp,Dept Pathol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Johns Hopkins Hosp,Dept Oncol, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Johns Hopkins Hosp,Dept Urol, Baltimore, MD 21287 USA
[4] Bloomberg Sch Publ Hlth, Baltimore, MD USA
关键词
D O I
10.1016/j.urology.2005.03.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine whether potential candidates for watchful waiting have undersampling of more substantial cancer. Methods. A total of 103 men were studied, who were predicted to have insignificant cancer in their radical prostatectomy (RP) specimen. All had limited cancer on routine needle biopsy (no core with more than 50% involvement; Gleason score less than 7, and fewer than 3 cores involved) with a serum prostate-specific antigen density of 0.15 or less. Insignificant tumor at RP was considered organ-confined tumor, no Gleason pattern 4 or 5, and a tumor volume of less than 0.5 cm(3). Saturation biopsy (average 44 cores) and an alternate biopsy saturation scheme with one half the number of cores using an 18-gauge Biopty gun was performed in the pathology laboratory on totally embedded and serially sectioned RP specimens. Results. Of the tumors, 97% were organ confined. The RP Gleason score was less than 7 in 84% of the cases. The RP tumor volume was 0.01 to 2.39 cm(3) (median 0.14). Of the cancer specimens, 71% were insignificant and 29% had been incorrectly classified before surgery using standard biopsy schemes. Using the full saturation biopsy scheme, if we predicted significant cancer, the probability of having insignificant cancer was only 11.5% (false-positive rate). If the model predicted insignificant cancer, the probability of significant cancer was also only 11.5% (false-negative rate; sensitivity 71.9% and specificity 95.8%). Using the alternate biopsy sampling scheme, the false-positive rate was 8% and the false-negative rate was 11.4% (sensitivity 71.9% and specificity 97.1%). Conclusions. Saturation biopsy provides accurate predictability of prostate tumor volume and grade to select suitable candidates for watchful waiting therapy.
引用
收藏
页码:356 / 360
页数:5
相关论文
共 14 条
[1]   Expectant management of nonpalpable prostate cancer with curative intent: Preliminary results [J].
Carter, HB ;
Walsh, PC ;
Landis, P ;
Epstein, JI .
JOURNAL OF UROLOGY, 2002, 167 (03) :1231-1234
[2]   Prospective evaluation of men with stage T1c adenocarcinoma of the prostate [J].
Carter, HB ;
Sauvageot, J ;
Walsh, PC ;
Epstein, JI .
JOURNAL OF UROLOGY, 1997, 157 (06) :2206-2209
[3]   Increasing incidence of minimal residual cancer in radical prostatectomy specimens [J].
DiGiuseppe, JA ;
Sauvageot, J ;
Epstein, JI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (02) :174-178
[4]   PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER [J].
EPSTEIN, JI ;
WALSH, PC ;
CARMICHAEL, M ;
BRENDLER, CB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05) :368-374
[5]   Importance of posterolateral needle biopsies in the detection of prostate cancer [J].
Epstein, JI ;
Walsh, PC ;
Carter, HB .
UROLOGY, 2001, 57 (06) :1112-1116
[6]   Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases [J].
Fleshner, N ;
Klotz, L .
UROLOGY, 2002, 60 (01) :93-97
[7]   Saturation prostate biopsy with periprostatic block can be performed in the office [J].
Jones, JS ;
Oder, M ;
Zippe, CD .
JOURNAL OF UROLOGY, 2002, 168 (05) :2108-2110
[8]   MORPHOMETRIC MEASUREMENT OF TUMOR VOLUME AND PERCENT OF GLAND INVOLVEMENT AS PREDICTORS OF PATHOLOGICAL STAGE IN CLINICAL STAGE-B PROSTATE-CANCER [J].
PARTIN, AW ;
EPSTEIN, JI ;
CHO, KR ;
GITTELSOHN, AM ;
WALSH, PC .
JOURNAL OF UROLOGY, 1989, 141 (02) :341-345
[9]   Parasagittal biopsies add minimal information in repeat saturation prostate biopsy [J].
Patel, AR ;
Jones, JS ;
Rabets, J ;
DeOreo, G ;
Zippe, CD .
UROLOGY, 2004, 63 (01) :87-89
[10]  
Pryor Michael B, 2002, Clin Prostate Cancer, V1, P172, DOI 10.3816/CGC.2002.n.019